Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons.
about
A protease-independent function for SPPL3 in NFAT activationRole of presenilin 1 in structural plasticity of cortical dendritic spines in vivoMitochondria-associated membranes as hubs for neurodegenerationA Low Affinity GCaMP3 Variant (GCaMPer) for Imaging the Endoplasmic Reticulum Calcium StoreLysosome and calcium dysregulation in Alzheimer's disease: partners in crimeAnalyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesDevelopment and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's diseaseCalpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) has InsP(3)-independent gating and disrupts intracellular Ca(2+) homeostasisLong-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic miceSuppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.Homeostatic disinhibition in the aging brain and Alzheimer's diseaseMutagenesis mapping of the presenilin 1 calcium leak conductance pore.Inositol trisphosphate receptor Ca2+ release channels in neurological diseases.NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.The C terminus of Bax inhibitor-1 forms a Ca2+-permeable channel pore.Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's diseaseNovel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk.General anesthetic isoflurane modulates inositol 1,4,5-trisphosphate receptor calcium channel opening.Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein.ER calcium and Alzheimer's disease: in a state of flux.Endoplasmic reticulum oxidoreductin-1-like β (ERO1lβ) regulates susceptibility to endoplasmic reticulum stress and is induced by insulin flux in β-cells.Endoplasmic reticulum Ca(2+) handling in excitable cells in health and diseaseConstitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.Presenilin-like GxGD membrane proteases have dual roles as proteolytic enzymes and ion channels.The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivationInositol 1,4,5-trisphosphate receptors in the endoplasmic reticulum: A single-channel point of view.Analyzing and Quantifying the Gain-of-Function Enhancement of IP3 Receptor Gating by Familial Alzheimer's Disease-Causing Mutants in Presenilins.Lack of evidence for presenilins as endoplasmic reticulum Ca2+ leak channelsMitochondrial Ca(2+) and neurodegenerationEarly presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice.Reduction of increased calcineurin activity rescues impaired homeostatic synaptic plasticity in presenilin 1 M146V mutant.Upregulated function of mitochondria-associated ER membranes in Alzheimer diseaseRole of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer diseaseEmergence of ion channel modal gating from independent subunit kinetics.Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease.Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines.Impaired mitochondrial function due to familial Alzheimer's disease-causing presenilins mutants via Ca(2+) disruptions.
P2860
Q24306596-27C3309A-580F-47BB-A19F-5DB2C2660866Q24338802-2E9D035F-3812-4F98-B1AD-F6AEBE44661CQ26770200-02CA1D05-FB72-4A7B-BD24-50B88CA84AB1Q27315982-CB806815-51C7-47B9-BD1A-66EF8658C2CEQ27693256-0FB40D6C-9552-4C31-9120-1B82D708F505Q28087158-EA1974D2-7BE6-4199-860A-965D41F9EBC4Q28535175-BF3355AE-32C5-4FA6-92DB-5C76019581B3Q28576191-0728D6A1-BA7D-476E-95AB-3890E699BD04Q30887483-95E6DEAF-655F-43BC-A27B-49B4A8E551ADQ33605796-54B927E3-5F04-423F-BAB6-0F975297A3E3Q33780879-2CE818BB-E38B-49DA-B7B6-E73892C24C3FQ33885492-5218B7A0-B046-4E1B-9A3A-FF662E945290Q33946097-E8042A3E-5628-4D95-B4BB-F10292437568Q34149384-20F08DD4-4756-4EA2-827F-0A31EF8373BEQ34203241-16961379-E6F0-4B73-800F-441F58BB41E5Q34236873-D8FD7BDC-CB03-406C-ABCB-D6B273A8254BQ34532864-3F9BD744-33F6-45D1-A05C-F5D22FBCEF49Q34547754-FD46E85E-8FDC-41BD-B57A-75BF7E9B92C1Q34571728-956C768C-2AA8-440A-8DEC-013378D77B31Q34582973-1F5F79E0-0612-4995-BC62-AB0CB1CE5A4FQ34799569-DFE41903-ADA9-418E-91F6-935BBF7A40DAQ34923956-C8F46715-0723-4BBF-AF53-70FA8A1BB7BDQ34966217-13B731BF-B4B9-4CB0-8192-98DD911036DDQ35046909-78C211D3-B91E-465D-BD0E-0103F3CF1305Q35122788-4FE7BDC6-6581-43E1-8B93-66F7119FB6FFQ35164866-1B88CD1F-8B3C-4EE3-B66C-A2D263123958Q35172983-94E946A1-47B0-4978-978D-C7958D7CA47EQ35484349-9A7059C1-2EE8-4BB9-9028-EA6AF3476A8AQ35691086-ABD66322-6531-44D2-84A5-DA880CE3DDECQ35800316-82706EFE-D6EC-49B0-9822-4089F024ECF5Q35879583-1EBB7FE9-EB8F-436E-80E5-E9B610915ADBQ36095330-AE70F565-286C-4230-84C6-8CA9B29D9186Q36158722-9F944121-1706-472A-8315-C75B57D37F70Q36271540-208172F8-A8EF-4F85-80D6-0ABB9671CB26Q36382102-667160BA-5AFA-43EF-A3B1-69D8E350B87FQ37180013-89BA3911-1E5C-4E58-94A5-D948291C5D8CQ37247653-0B4EEDD0-E40A-400C-8A15-DF362E3FDA5CQ37293997-60C1E184-E973-497D-BB87-689F4E5C3243Q37350927-68CF7C41-D2A8-4DA7-8BA4-79C66B09FA0CQ37383808-26AF5C76-8D84-4EC3-8551-276CD581BF69
P2860
Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Gain-of-function enhancement o ...... human cells and mouse neurons.
@ast
Gain-of-function enhancement o ...... human cells and mouse neurons.
@en
type
label
Gain-of-function enhancement o ...... human cells and mouse neurons.
@ast
Gain-of-function enhancement o ...... human cells and mouse neurons.
@en
prefLabel
Gain-of-function enhancement o ...... human cells and mouse neurons.
@ast
Gain-of-function enhancement o ...... human cells and mouse neurons.
@en
P2093
P2860
P1433
P1476
Gain-of-function enhancement o ...... human cells and mouse neurons.
@en
P2093
David E Kang
Don-On Daniel Mak
Ikuo Hayashi
J Kevin Foskett
King-Ho Cheung
Lijuan Mei
Takeshi Iwatsubo
P2860
P356
10.1126/SCISIGNAL.2000818
P577
2010-03-23T00:00:00Z